Design and synthesis of some novel triazine-tyrosine hybrids as potential agents for the treatment of multiple sclerosis

BACKGROUND AND PURPOSE: One of the most noteworthy methods to slow down multiple sclerosis (MS) progress is a decrease of lymphocyte cells via S1P1 receptor modulating. Here, a series of S1P1 receptor modulators were designed and investigated for their ability to decrease lymphocytes in a rat model....

Descripción completa

Detalles Bibliográficos
Autores principales: Saeidi, Sajjad, Asadi, Parvin, Hassanzadeh, Farshid, Aliomrani, Mehdi, Khodarahmi, Ghadam Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661688/
https://www.ncbi.nlm.nih.gov/pubmed/36386488
http://dx.doi.org/10.4103/1735-5362.355208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661688/
https://www.ncbi.nlm.nih.gov/pubmed/36386488
http://dx.doi.org/10.4103/1735-5362.355208

Ejemplares similares